The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bladder Cancer Multidisciplinary Clinic (BCMC) model: Impact on imaging, pathology and treatment recommendations.
 
Brian Winters
No Relationships to Disclose
 
Leonidas Nikolaos Diamantopoulos
No Relationships to Disclose
 
Maria S. Tretiakova
No Relationships to Disclose
 
Lawrence D. True
Stock and Other Ownership Interests - Lightspeed Microscopy
Research Funding - Ventana Medical Systems
Patents, Royalties, Other Intellectual Property - Lens on an open-top lightsheet microscope
 
Jean H Lee
No Relationships to Disclose
 
Jing Zeng
No Relationships to Disclose
 
Jay Justin Liao
No Relationships to Disclose
 
Heather H. Cheng
Research Funding - Astellas Medivation (Inst); Clovis Oncology (Inst); Color Genomics Foundation (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Sanofi (Inst)
 
Michael Thomas Schweizer
Consulting or Advisory Role - Janssen
Research Funding - AstraZeneca (Inst); Janssen (Inst); Madison Vaccines, Inc. (Inst); Pfizer (Inst); Roche (Inst); Zenith Epigenetics (Inst)
 
Andrew Caleb Hsieh
Honoraria - Hotspot Therapeutics
Research Funding - eFFECTOR Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - MTOR modulators and uses thereof Patent number: 9629843; USE OF TRANSLATIONAL PROFILING TO IDENTIFY TARGET MOLECULES FOR THERAPEUTIC TREATMENT Publication number: 20140288097
 
Evan Y. Yu
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Churchill Pharmaceuticals; Dendreon; EMD Serono; Incyte; Janssen; Merck; QED Therapeutics; Seagen; Tolmar
Research Funding - Agensys (Inst); Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Genentech/Roche (Inst); Merck (Inst); Seagen (Inst)
 
George R Schade
Patents, Royalties, Other Intellectual Property - Global Cancer Technology
 
John L. Gore
No Relationships to Disclose
 
Daniel W. Lin
Consulting or Advisory Role - Astellas Pharma; Clovis Oncology; Dendreon
Research Funding - GenomeDx (Inst); Genomic Health (Inst); MDxHealth (Inst)
 
Manjiri Dighe
Research Funding - Philips Healthcare
 
Funda Vakar-Lopez
Patents, Royalties, Other Intellectual Property - Bloodworks Northwest (I)
 
Kenneth J. Russell
Consulting or Advisory Role - Varian Medical Systems
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Biocept; Bristol-Myers Squibb; Clovis Oncology; Driver, Inc; EMD Serono; Foundation Medicine; Genentech; HERON; Janssen; Merck; Pfizer; QED Therapeutics; Seagen
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - AstraZeneca (Inst); Bavarian Nordic (Inst); Bayer (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)
 
Robert B. Montgomery
Research Funding - AstraZeneca; ESSA; Ferring; Janssen Oncology
 
Jonathan L. Wright
Speakers' Bureau - Foundation Health Partners J. Michael Carroll Cancer Center; OncLive; seattle cancer care alliance
Research Funding - Altor BioScience; Merck; Nucleix
Other Relationship - Movember Foundation; UpToDate